Consistent with its role supporting oncogene expression, IGF2BP1 was reported as a posttranscriptional driver of tumor cell proliferation, migration, metastatic potential, and therapy resistance [13, 14]. The gene discussed is IGF2BP1; the disease is neoplasm.